Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lahner

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 13, 2011
Chemotherapy in patients with progressive, undifferentiated neuroendocrine tumors: a single-center experienceT Deutschbein, N Unger, A Yuece, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 14, 2011
Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine: a single-center experienceT Deutschbein, A Matuszczyk, L C Moeller, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|November 30, 2019
[Pheochromocytomatosis after adrenalectomy: metastasis or cell seeding?]F Weber, J Belker, N Unger, et al.
European Journal of Endocrinology|December 22, 2000
Effects of growth hormone replacement therapy on levels of cortisol and cortisol-binding globulin in hypopituitary adultsM Tschöp, H Lahner, H Feldmeier, et al.
Nuklearmedizin. Nuclear Medicine|February 17, 2015
[Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours. German Guideline (S1)]T D Poeppel, C Boy, A Bockisch, et al.
Nuklearmedizin. Nuclear Medicine|March 15, 2018
[Somatostatin receptor PET/CT (SSTR-PET/CT)]C Boy, T Poeppel, J Kotzerke, et al.
Journal of Neuroendocrinology|April 30, 2025
PRRT plus holmium-166-SIRT (HEPAR PLuS) versus PRRT-only in patients with metastatic neuroendocrine tumors: A propensity-score matched analysisW B Veldhuis, T Walter, D M V de Vries-Huizing, et al.
Der Pathologe|March 28, 2014
[Neuroendocrine neoplasms of the distal jejunum and ileum]M Anlauf, B Sipos, I Boeck, et al.
Der Pathologe|May 20, 2015
[Neuroendocrine neoplasms of the breast]M Anlauf, M Neumann, S Bomberg, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 13, 2011
Chemotherapy in patients with progressive, undifferentiated neuroendocrine tumors: a single-center experienceT Deutschbein, N Unger, A Yuece, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 14, 2011
Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine: a single-center experienceT Deutschbein, A Matuszczyk, L C Moeller, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|November 30, 2019
[Pheochromocytomatosis after adrenalectomy: metastasis or cell seeding?]F Weber, J Belker, N Unger, et al.
European Journal of Endocrinology|December 22, 2000
Effects of growth hormone replacement therapy on levels of cortisol and cortisol-binding globulin in hypopituitary adultsM Tschöp, H Lahner, H Feldmeier, et al.
Nuklearmedizin. Nuclear Medicine|February 17, 2015
[Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours. German Guideline (S1)]T D Poeppel, C Boy, A Bockisch, et al.
Nuklearmedizin. Nuclear Medicine|March 15, 2018
[Somatostatin receptor PET/CT (SSTR-PET/CT)]C Boy, T Poeppel, J Kotzerke, et al.
Journal of Neuroendocrinology|April 30, 2025
PRRT plus holmium-166-SIRT (HEPAR PLuS) versus PRRT-only in patients with metastatic neuroendocrine tumors: A propensity-score matched analysisW B Veldhuis, T Walter, D M V de Vries-Huizing, et al.
Der Pathologe|March 28, 2014
[Neuroendocrine neoplasms of the distal jejunum and ileum]M Anlauf, B Sipos, I Boeck, et al.
Der Pathologe|May 20, 2015
[Neuroendocrine neoplasms of the breast]M Anlauf, M Neumann, S Bomberg, et al.
Pageof 2